Company Overview and News

 
Greenply Industries Limited - Shareholders meeting

2018-08-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

 
Greenply Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-08-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

 
Greenply Industries Limited - Financial Result Updates

2018-08-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

 
Greenply Industries Limited - Investor Presentation

2018-08-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

 
Greenply Industries Limited - Updates

2018-08-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

 
Greenply Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-08-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

 
Greenply Industries to list demerged entity Greenpanel in Q4 of FY19

2018-07-16 thehindubusinessline
V Rishi Kumar Greenply Industries, a leading manufacturer of plywood, is likely to see the demerged MDF business listing in the fourth quarter of this fiscal.
526797 GREENPLY

5
Market Live: Sensex rises over 100 pts, Nifty above 10,700; Vedanta, Bharti Infratel top losers

2018-07-03 moneycontrol
Market Update: The market is off its day's high in afternoon as investors closely monitor trade developments between the US and China, and also await June quarter earnings season that will be kicked off next week.
GRASIM 500325 UBL ASIANPAINT 532478 CADILAHC 532321 534816 MS 500570 RLNIY ASHOKLEY GRSJY AXB TATAPOWER YYBKY AKLD AXBA BAJAJFINSV 532670 500180 526797 500300 507458 AKLS BHRYY 500820 RELIANCE IDBI 532737 532978 RENUKA 532215 AXISBANK RIGD GREENPLY INFRATEL HDFCBANK 500477 TATAMOTORS YESBANK 500116 IBN UBHOLDINGS 532967 532648 KIRIINDUS UNBWY CDLYY AXBKY GRSXY ICICIBANK EMKAY HDB 532174 TPCL 500400 TTM

1
Market Live: Sensex gains strength, Nifty reclaims 10,700; Nikkei, Shanghai recover from day#39;s low

2018-07-03 moneycontrol
Market Expert: Dhananjay Sinha, Head of Research, Economist and Strategist, Emkay Global Financial Services told CNBC-TV18 that the announcement of minimum support price (MSP) is critical even if it’s coming with a delay.
GRASIM 500325 UBL ASIANPAINT 532478 534816 MS RLNIY ASHOKLEY GRSJY TATAPOWER YYBKY AKLD 532670 500180 526797 500300 507458 AKLS BHRYY 500820 RELIANCE IDBI 532737 RENUKA RIGD GREENPLY INFRATEL HDFCBANK 500477 YESBANK 500116 IBN UBHOLDINGS 532648 UNBWY GRSXY ICICIBANK EMKAY HDB 532174 TPCL 500400

1
Market Live: Midcap underperforms Sensex; RIL, TCS, Infosys, HDFC Bank support

2018-07-03 moneycontrol
Govt wants to close IDBI-LIC deal in next three months: Finance Ministry official said insurance major LIC would independently value IDBI Bank, reports CNBC-TV18 quoting NewsRise.
GRASIM BHRYY 500325 500820 RELIANCE IDBI ASIANPAINT 534816 RIGD GREENPLY HDFCBANK 500477 INFRATEL MS RLNIY ASHOKLEY YESBANK GRSJY 500116 IBN TATAPOWER 532648 YYBKY AKLD GRSXY ICICIBANK HDB 532174 500180 526797 500300 TPCL 500400 AKLS

 
Greenply Industries up 5% post commercial production starts at Andhra unit

2018-07-03 moneycontrol
Shares of Greenply Industries added 5.6 percent intraday Tuesday after company commenced commercial production at Andhra unit.
526797 GREENPLY

 
Market Live: Nifty holds 10,650 despite correction in Asian peers; ONGC, Hero top gainers

2018-07-03 moneycontrol
Greenply in Focus: Shares of Greenply Industries added 5.6 percent in morning after company commenced commercial production at Andhra unit.
GRASIM BHRYY 500820 IDBI ASIANPAINT 534816 GREENPLY 500477 INFRATEL ASHOKLEY YESBANK GRSJY 500116 IBN TATAPOWER 532648 YYBKY AKLD GRSXY ICICIBANK 532174 526797 500300 TPCL 500400 AKLS

 
Greenply Industries Limited - Updates

2018-07-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
526797 GREENPLY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

10h - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

10h - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

12h - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...